跳至主要内容
临床试验/RBR-4jx82p
RBR-4jx82p招募中未知

Effect of early parenteral alaninaglutamine dipeptide complementation on inflammatory markers and prognostic indexes in critically ill patients after major abdominal surgery

Eliseuda Marinho da Silva0 个研究点开始时间: 2020年1月15日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 90Y(—)

入选标准

  • Ages 18-90 years; after major abdominal surgery in ICU; contraindication or failure of enteral nutrition within 48 hours; use of parenteral nutrition for at least 7 days; no history of kidney or liver disease

排除标准

  • Life expectancy greater than 7 days, ie palliative care; unstable hemodynamic state; chronic renal failure where dialysis is insufficient; previous history of severe 24-hour sepsis; liver failure with hepatic encephalopathy or portal hypertension; pre-existing endocrine disorders; continuous 24-hour propofol infusion;
  • chronic maintenance of systemic steroid therapy; immunocompromise; pregnancy or lactation; severe brain injury;
  • seizure disorder with anticonvulsant medication; metastatic cancer of lymphoma four; psychiatric history; family members unable to understand the nature and scope of the study

研究者

发起方
Eliseuda Marinho da Silva

相似试验